About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Btktm1Gsv
targeted mutation 1, Frank Grosveld
MGI:2449487
Summary 5 genotypes
Jump to Allelic Composition Genetic Background Genotype ID
ht1
Btktm1Gsv/Btk+ involves: 129P2/OlaHsd * C57BL/6 MGI:3709376
cx2
Blnktm1Pjln/Blnktm1Pjln
Btktm1Gsv/Y
involves: 129P2/OlaHsd * BALB/c * C57BL/6 MGI:3709377
cx3
Blnktm1Pjln/Blnktm1Pjln
Btktm1Gsv/Y
Tg(CD19-BTK*K430R)XK24Rwhe/?
involves: 129P2/OlaHsd * BALB/c * C57BL/6 * FVB MGI:3709379
cx4
Btktm1Gsv/Y
Tg(CD19-BTK*K430R)XK24Rwhe/?
involves: 129P2/OlaHsd * C57BL/6 * FVB MGI:3709381
ot5
Btktm1Gsv/Y involves: 129P2/OlaHsd * C57BL/6 MGI:2449488


Genotype
MGI:3709376
ht1
Allelic
Composition
Btktm1Gsv/Btk+
Genetic
Background
involves: 129P2/OlaHsd * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Btktm1Gsv mutation (0 available); any Btk mutation (10 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
immune system
• decreased number of B220+ cells peripherally (J:35769)
• decreased number of B220+ cells peripherally (J:35769)
• reduced numbers of mature IgM-IgD+ B cells (J:35769)
• reduced numbers of mature IgM-IgD+ B cells (J:35769)
• deficiency of CD5+ B cells in the peritoneum for B cells expressing both the mutant and the wild-type allele (J:35769)
• deficiency of CD5+ B cells in the peritoneum for B cells expressing both the mutant and the wild-type allele (J:35769)

hematopoietic system
• decreased number of B220+ cells peripherally (J:35769)
• decreased number of B220+ cells peripherally (J:35769)
• reduced numbers of mature IgM-IgD+ B cells (J:35769)
• reduced numbers of mature IgM-IgD+ B cells (J:35769)
• deficiency of CD5+ B cells in the peritoneum for B cells expressing both the mutant and the wild-type allele (J:35769)
• deficiency of CD5+ B cells in the peritoneum for B cells expressing both the mutant and the wild-type allele (J:35769)




Genotype
MGI:3709377
cx2
Allelic
Composition
Blnktm1Pjln/Blnktm1Pjln
Btktm1Gsv/Y
Genetic
Background
involves: 129P2/OlaHsd * BALB/c * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Blnktm1Pjln mutation (0 available); any Blnk mutation (51 available)
Btktm1Gsv mutation (0 available); any Btk mutation (10 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
immune system
• B cell development is completely blocked (J:94768)
• B cell development is completely blocked (J:94768)
• dramatic reductions of immature IgM+IgD- B cells in the bone marrow (J:94768)
• dramatic reductions of immature IgM+IgD- B cells in the bone marrow (J:94768)
• dramatic reductions of mature IgM+IgD+ B cells in the bone marrow (J:94768)
• dramatic reductions of mature IgM+IgD+ B cells in the bone marrow (J:94768)
• IgG3 severely reduced (J:94768)
• IgG3 severely reduced (J:94768)
• severely reduced (J:94768)
• severely reduced (J:94768)

tumorigenesis
• increased frequency of pre-B cell lymphomas (J:94768)
• increased frequency of pre-B cell lymphomas (J:94768)

hematopoietic system
• B cell development is completely blocked (J:94768)
• B cell development is completely blocked (J:94768)
• dramatic reductions of immature IgM+IgD- B cells in the bone marrow (J:94768)
• dramatic reductions of immature IgM+IgD- B cells in the bone marrow (J:94768)
• dramatic reductions of mature IgM+IgD+ B cells in the bone marrow (J:94768)
• dramatic reductions of mature IgM+IgD+ B cells in the bone marrow (J:94768)
• IgG3 severely reduced (J:94768)
• IgG3 severely reduced (J:94768)
• severely reduced (J:94768)
• severely reduced (J:94768)




Genotype
MGI:3709379
cx3
Allelic
Composition
Blnktm1Pjln/Blnktm1Pjln
Btktm1Gsv/Y
Tg(CD19-BTK*K430R)XK24Rwhe/?
Genetic
Background
involves: 129P2/OlaHsd * BALB/c * C57BL/6 * FVB
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Blnktm1Pjln mutation (0 available); any Blnk mutation (51 available)
Btktm1Gsv mutation (0 available); any Btk mutation (10 available)
Tg(CD19-BTK*K430R)XK24Rwhe mutation (0 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
immune system
• B cell development is partially restored, by about 4-7 fold (J:94768)
• some differentiation into mature B cells occurs (J:94768)
• recirculationg B cell population in the bone marrow is improved (J:94768)
• recirculationg B cell population in the bone marrow is improved (J:94768)
• B cell development is partially restored, by about 4-7 fold (J:94768)
• some differentiation into mature B cells occurs (J:94768)
• IgG3 levels remain severely reduced (J:94768)
• IgG3 levels remain severely reduced (J:94768)
• improved or restored (J:94768)
• improved or restored (J:94768)

tumorigenesis
N
• tumor suppressor function is restored (J:94768)
• tumor suppressor function is restored (J:94768)

hematopoietic system
• B cell development is partially restored, by about 4-7 fold (J:94768)
• some differentiation into mature B cells occurs (J:94768)
• recirculationg B cell population in the bone marrow is improved (J:94768)
• B cell development is partially restored, by about 4-7 fold (J:94768)
• some differentiation into mature B cells occurs (J:94768)
• recirculationg B cell population in the bone marrow is improved (J:94768)
• IgG3 levels remain severely reduced (J:94768)
• IgG3 levels remain severely reduced (J:94768)
• improved or restored (J:94768)
• improved or restored (J:94768)




Genotype
MGI:3709381
cx4
Allelic
Composition
Btktm1Gsv/Y
Tg(CD19-BTK*K430R)XK24Rwhe/?
Genetic
Background
involves: 129P2/OlaHsd * C57BL/6 * FVB
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Btktm1Gsv mutation (0 available); any Btk mutation (10 available)
Tg(CD19-BTK*K430R)XK24Rwhe mutation (0 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
immune system
N
• calcium signaling of splenic B cells is restored (J:94768)
• calcium signaling of splenic B cells is restored (J:94768)
• B cell apoptosis is reduced compared to similar mice lacking the transgene (J:120989)
• B cell apoptosis is reduced compared to similar mice lacking the transgene (J:120989)
• restored B220+ cell numbers peripherally (J:120989)
• restored B220+ cell numbers peripherally (J:120989)
• deficiency of CD5+ B cells in the peritoneum remains (J:120989)
• deficiency of CD5+ B cells in the peritoneum remains (J:120989)
• differentiation is partially restored (J:120989)
• differentiation is partially restored (J:120989)
• decreased lambda light chain usage (J:120989)
• decreased lambda light chain usage (J:120989)

hematopoietic system
• B cell apoptosis is reduced compared to similar mice lacking the transgene (J:120989)
• B cell apoptosis is reduced compared to similar mice lacking the transgene (J:120989)
• restored B220+ cell numbers peripherally (J:120989)
• restored B220+ cell numbers peripherally (J:120989)
• deficiency of CD5+ B cells in the peritoneum remains (J:120989)
• deficiency of CD5+ B cells in the peritoneum remains (J:120989)
• differentiation is partially restored (J:120989)
• differentiation is partially restored (J:120989)
• decreased lambda light chain usage (J:120989)
• decreased lambda light chain usage (J:120989)

cellular
• B cell apoptosis is reduced compared to similar mice lacking the transgene (J:120989)
• B cell apoptosis is reduced compared to similar mice lacking the transgene (J:120989)




Genotype
MGI:2449488
ot5
Allelic
Composition
Btktm1Gsv/Y
Genetic
Background
involves: 129P2/OlaHsd * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Btktm1Gsv mutation (0 available); any Btk mutation (10 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
immune system
• development through to large pre-B cell stage is normal (J:35769)
• transition from pre-B to immature B cell is impaired (J:35769)
• development through to large pre-B cell stage is normal (J:35769)
• transition from pre-B to immature B cell is impaired (J:35769)
• decreased number of B220+ cells peripherally (J:35769)
• thymocyte and T cell numbers are unaffected (J:35769)
• decreased number of B220+ cells peripherally (J:35769)
• thymocyte and T cell numbers are unaffected (J:35769)
• reduced IgM+IgD- to about 70% of normal numbers at 5 weeks of age (J:35769)
• reduced IgM+IgD- to about 70% of normal numbers at 5 weeks of age (J:35769)
• mature IgMlowIgDhigh are nearly absent (J:35769)
• mature IgMlowIgDhigh are nearly absent (J:35769)
• deficiency of CD5+ B cells in the peritoneum (J:35769)
• deficiency of CD5+ B cells in the peritoneum (J:35769)
• significantly reduced calcium signaling in splenic B cells (J:94768)
• significantly reduced calcium signaling in splenic B cells (J:94768)
• decreased lambda light chain usage (J:120989)
• decreased lambda light chain usage (J:120989)
• IgG3 reduced 20% at 5 weeks of age (J:35769)
• IgG3 reduced 20% at 5 weeks of age (J:35769)
• reduced 50% at 5 weeks of age (J:35769)
• reduced 50% at 5 weeks of age (J:35769)
• no response to T cell independent type II antigens (J:120989)
• no response to T cell independent type II antigens (J:120989)

hematopoietic system
• development through to large pre-B cell stage is normal (J:35769)
• transition from pre-B to immature B cell is impaired (J:35769)
• development through to large pre-B cell stage is normal (J:35769)
• transition from pre-B to immature B cell is impaired (J:35769)
• reduced IgM+IgD- to about 70% of normal numbers at 5 weeks of age (J:35769)
• reduced IgM+IgD- to about 70% of normal numbers at 5 weeks of age (J:35769)
• decreased number of B220+ cells peripherally (J:35769)
• thymocyte and T cell numbers are unaffected (J:35769)
• decreased number of B220+ cells peripherally (J:35769)
• thymocyte and T cell numbers are unaffected (J:35769)
• mature IgMlowIgDhigh are nearly absent (J:35769)
• mature IgMlowIgDhigh are nearly absent (J:35769)
• deficiency of CD5+ B cells in the peritoneum (J:35769)
• deficiency of CD5+ B cells in the peritoneum (J:35769)
• significantly reduced calcium signaling in splenic B cells (J:94768)
• significantly reduced calcium signaling in splenic B cells (J:94768)
• decreased lambda light chain usage (J:120989)
• decreased lambda light chain usage (J:120989)
• IgG3 reduced 20% at 5 weeks of age (J:35769)
• IgG3 reduced 20% at 5 weeks of age (J:35769)
• reduced 50% at 5 weeks of age (J:35769)
• reduced 50% at 5 weeks of age (J:35769)

Mouse Models of Human Disease
OMIM ID Ref(s)
Agammaglobulinemia, X-Linked; XLA 300755 J:35769





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Tumor Biology (MTB), Gene Ontology (GO), MouseCyc
Citing These Resources
Funding Information
Warranty Disclaimer & Copyright Notice
Send questions and comments to User Support.
last database update
02/02/2016
MGI 6.02
The Jackson Laboratory